Skip to main content
Top
Literature
2.
go back to reference Argemi X, Prévost G, Riegel P et al (2017) VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis. Clin Microbiol Infect 23:334.e1–334.e8. doi:10.1016/j.cmi.2016.12.018 CrossRef Argemi X, Prévost G, Riegel P et al (2017) VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis. Clin Microbiol Infect 23:334.e1–334.e8. doi:10.​1016/​j.​cmi.​2016.​12.​018 CrossRef
Metadata
Title
Comment on the article “Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices”
Author
Xavier Argemi
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 11/2017
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-017-3586-z

Other articles of this Issue 11/2017

International Orthopaedics 11/2017 Go to the issue